Trademark: 90262583
Status Date
Monday, December 11, 2023
Filing Date
Monday, October 19, 2020
Published for Opposition
Tuesday, April 27, 2021
5 Pharmaceutical preparations and substances for the treatment of human diseases and medical conditions, namely, cancer, infections, infectious diseases, inflammatory disorders, immune system disorders, autoimmune disorders and transplant rejection; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors for stem cells in stem cell mobilization, immune system stimulators and immune system modulators; Diagnostic agents, preparations and substances for medical purposes
Dec 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2023
Sou Extension 5 Granted
Dec 1, 2023
Sou Extension 5 Filed
Dec 11, 2023
Case Assigned To Intent To Use Paralegal
Dec 1, 2023
Sou Teas Extension Received
May 27, 2023
Notice Of Approval Of Extension Request E-Mailed
May 25, 2023
Sou Extension 4 Granted
May 25, 2023
Sou Extension 4 Filed
May 25, 2023
Sou Teas Extension Received
Dec 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2022
Sou Extension 3 Granted
Nov 29, 2022
Sou Extension 3 Filed
Nov 29, 2022
Sou Teas Extension Received
Jun 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 21, 2022
Sou Extension 2 Granted
Jun 21, 2022
Sou Extension 2 Filed
Jun 21, 2022
Sou Teas Extension Received
Dec 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2021
Sou Extension 1 Granted
Dec 3, 2021
Sou Extension 1 Filed
Dec 3, 2021
Sou Teas Extension Received
Jun 22, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 27, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2021
Published For Opposition
Apr 7, 2021
Notification Of Notice Of Publication E-Mailed
Mar 19, 2021
Approved For Pub - Principal Register
Mar 18, 2021
Assigned To Examiner
Dec 6, 2020
New Application Office Supplied Data Entered
Oct 22, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
